Aviad Friedman - Jan 3, 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Aviad Friedman
Stock symbol
ORMP
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 07:30 PM
Previous filing
Oct 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +6K 6K Jan 3, 2022 Direct F1
transaction ORMP Common Stock Gift $0 -6K -100% $0.00* 0 Jan 3, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option (right to buy Award $0 +10K $0.00 10K Jan 3, 2022 Common Stock 10K $13.89 Direct F3
transaction ORMP Stock Option (right to buy Gift $0 -10K -100% $0.00* 0 Jan 3, 2022 Common Stock 10K $13.89 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2 These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee.
F3 The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.